With an aim to empower people to personalize their health checkups and make informed lifestyle choices that can subsequently delay/prevent the onset of diseases, Indus Health Plus, a pioneer in the preventive healthcare sector, is planning to invest Rs.75 crore over next 3-4 years to expand its personal genetic testing, DNAwise to half a million population pan India.
A majority of the fund will be used to create awareness among people about importance of personalized genetic testing in preventive healthcare. A portion of the fund will be used for technology advancement and human resource development, said Amol Naikawadi, joint managing director, Indus Health Plus.
The healthcare firm has launched DNAwise in Mumbai on December 11 at a cost of Rs.2 crore. Based on Illumina’s global screening array technology, DNAwise is a personal genetic test that decodes 7 lakh markers in the genetic makeup and generates a report after 4-6 weeks through which one can understand the health risks & personalize diet and fitness according to what suits them the best.
DNAwise is designed for all age groups and has 60 parameters related to health, nutrition and fitness. The package is available pan India, at Rs.14,999+GST and includes saliva sample kit delivered at one’s doorstep, report and telephonic counseling by a qualified genetic counselor.
Country like India where 55.4% deaths are due to non communicable diseases (NCDs). Personalised genetic test which helps identify risk factors for NCDs in advance plays a crucial role in controlling NCD deaths, said Naikawadi.
The growing number of lifestyle diseases, irrespective of the age groups, stimulated us to create this unique platform of prevention. In an endeavor to create healthy future for individuals by expanding the umbrella of prevention, we have come up with DNAwise, he added.
DNAwise analyses the health risks and food & fitness traits on the basis of one’s genetics. Knowing the genetic predispositions to various diseases helps an individual to delay/prevent the onset of diseases by modifying lifestyle. Healthy lifestyle attenuates genetic risk for diseases, he added.
DNAwise is once-in-a-lifetime investment for health that is recommended for all family members to know the predisposition of diseases, followed by yearly health examination. The genetic test report can be the guide for one’s lifelong wellness. A successful pilot project of DNAwise genetic test was conducted recently across 17 Indian cities covering 3,000 people. It was accepted very well amongst the consumers and they are now taking it for their family members, said joint managing director of Indus Health Plus.
With 18 years’ experience in preventive healthcare segment, Indus Health Plus has clocked a revenue of Rs.100 for fiscal 2017-18. The healthcare company aims to become a leader in personalized genetic test segment in less than a year.
The company has touched lives 6 lakh families and enabled them to live better through its comprehensive healthcare and wellness packages available at 122 centres in 78 cities pan India.